Innovative Product Recognition Blossom Innovations has received the 2020 Innovation of the Year Award at the IMCAS World Congress for its S3 Inject platform, highlighting advanced, award-winning dermatology and aging science technologies that can attract healthcare providers seeking cutting-edge treatments.

Growing Market Focus With a strategic emphasis on dermatology, aesthetics, and photobiology, Blossom Innovations is positioned to target clinics and practitioners in high-growth sectors that are investing in non-invasive aesthetic and skin rejuvenation solutions.

Investment and Funding Having secured $9M in funding and generating revenues between $1M and $10M, the company demonstrates strong potential for expansion, offering opportunities to collaborate on new product development or distribution channels within the medical device and therapeutics market.

Niche Technology Development Focusing on sustainable innovations in device technologies and drug/device combinations, Blossom Innovations presents opportunities to partner with organizations seeking innovative treatment platforms leveraging photobiology and dermatological therapy.

Industry Visibility As a Boston-based private company recognized for innovation and operating in a competitive landscape with larger firms, Blossom Innovations offers potential sales avenues through targeted outreach to aesthetic clinics, dermatologists, and aesthetic medicine suppliers.